BRVE
Braveheart Bio, Inc. - Common Stock (BRVE)
$75
About Braveheart Bio, Inc. - Common Stock (BRVE)
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
Details
Daily high
$28.50
Daily low
$25.76
Price at open
$27.64
52 Week High
$32.00
52 Week Low
$18.00
Market cap
2.1B
Dividend yield
-
Volume
214,969
Avg. volume
775,729
P/E ratio
--
Braveheart Bio, Inc. - Common Stock News
Details
Daily high
$28.50
Daily low
$25.76
Price at open
$27.64
52 Week High
$32.00
52 Week Low
$18.00
Market cap
2.1B
Dividend yield
-
Volume
214,969
Avg. volume
775,729
P/E ratio
--